Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
What is the ticker symbol for Bone Biologics Corp? What does BBLG stand for in stocks?
BBLG is the stock ticker symbol of Bone Biologics Corp. Every public company that trades on a stock exchange gets a ticker symbol.
What is the market capital of Bone Biologics Corp (BBLG)?
As of Thu Dec 26 2024, market cap of Bone Biologics Corp is 2.34 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.
What is the fair value of BBLG stock?
You can check BBLG's fair value in chart for subscribers.
Is Bone Biologics Corp a good stock to buy?
The fair value guage provides a quick view whether BBLG is over valued or under valued. Whether Bone Biologics Corp is cheap or expensive depends on the assumptions which impact Bone Biologics Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BBLG.